The primary focus of Dr. Amezcua’s research involves defining genetic and ethnic contributions in MS, with an emphasis on defining differences in disease expression and progression in individuals of Hispanic descent. Her studies are designed to identify high-risk subgroups of patients who may be at risk for disease progression and could benefit from earlier, aggressive treatments, such as those with opticospinal forms of MS that are more commonly observed in individuals of Asian ancestry. In addition, she plans to address the influence of migration, environmental factors, such as Vitamin D, and genetic factors on responses to treatment MS in this population. Recently, Dr. Amezcua has expanded her studies to include genome-wide association studies (GWAS) to identify the association of ancestral genes that are differently distributed in human populations with clinical and radiological manifestations of MS and response to treatment.
Dr. Amezcua is a recipient of the Nancy Davis Junior Investigator Award and an NIH KL2 award through the USC Clinical and Translational Sciences Institute (CTSI). She serves on multiple local and national committee's of the NMSS: the Clinical Advisory Committee for the California and Nevada Chapter of the NMSS, is a council member of the NMSS Hispanic MS Advisory Board and was recently elected to serve in the Access to Care Task Force of the NMSS. She is also working together with the NMSS to develop and bring MS services to the newly opened Wellness Center of the historic Los Angeles County Hospital.
We are very excited that Dr. Amezcua will be sharing her expertise with us!